PNC-27 is a peptide developed for its ability to target and destroy certain types of unhealthy cells, particularly cancer cells. It works by attaching to specific cell membranes, creating pores that allow the cells to die off naturally. While its still undergoing clinical research, it has caught attention for its targeted action. Although not a replacement for conventional treatments, PNC-27 is being explored as an alternative or complementary option in early-stage trials. Some people turn to it in experimental or off-label settings, often in coordination with medical professionals.